LAI Antipsychotics are Not a "Last Resort" Says Drs Citrome and Chepke

Long-acting injectable antipsychotics (LAIs) allow patients with schizophrenia to take control of their illness and should be utilized earlier in the treatment algorithm, said Psych Congress Steering Committee Member, Craig Chepke, MD, FAPA, and Pysch Congress Network's Schizophrenia Section Editor, Leslie Citrome, MD, MPH, in a recent live Q&A session at the virtual Psych Congress Regionals.

In this podcast, they discuss the roles long-acting injectables (LAIs) can play in schizophrenia treatment plans and expand on their May 6, 2022 session titled "Breaking Down the Barriers to Utilizing Long-Acting Injectable Antipsychotics for Schizophrenia Management."

Saundra Jain, MA, PsyD, LPC, adjunct clinical affiliate, University of Texas at Austin School of Nursing, moderates the discussion.

To register for the next Psych Congress Regionals meeting in your time zone, visit the meeting website.

Transcript coming soon.

Dr Craig Chepke is a Board-Certified psychiatrist and a Fellow of the American Psychiatric Association. He attended NYU School of Medicine and completed his residency training at Duke University. Dr Chepke is the medical director of Excel Psychiatric Associates in Huntersville, NC as well as a clinical assistant professor of psychiatry at SUNY Upstate Medical University and an Adjunct Associate Professor of Psychiatry for Atrium Health. He is a member of the Huntington Study Group and serves on the board of directors for the CURESZ foundation, a nonprofit organization dedicated to improving the lives of people living with Schizophrenia.

Dr Citrome is clinical professor of psychiatry and behavioral sciences at New York Medical College in Valhalla, New York, and adjunct clinical professor of psychiatry, Icahn School of Medicine at Mount Sinai in New York City, New York. In addition to his academic positions, he has a private practice in psychiatry in Pomona, New York, and is a volunteer consultant to the Assertive Community Treatment team/Mental Health Association of Rockland County. He is a Distinguished Life Fellow of the American Psychiatric Association and a Fellow of the American Society of Clinical Psychopharmacology where he currently serves as President. Dr Citrome is editor emeritus, International Journal of Clinical Practice where he was editor-in-chief 2013-2019; psychiatry topic editor for Clinical Therapeutics; editor for the American Society of Clinical Psychopharmacology Corner in the Journal of Clinical Psychiatry; section editor for psychopharmacology for Current Psychiatry; and also serves as an editorial board member for several other medical journals.